Thrombolytic therapy for treatment of pulmonary embolism in the postoperative period: Case report and review of the literature

Journal of Clinical Anesthesia

Volumn 8, Issue 8, 1996, Pages 669-674

  Hartmannsgruber, Maximilian W B ^a   Trent, Frederick L ^a   Stolzfus, Daniel P ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Department of Anesthesiology ^*

Author keywords

heparin; obesity; postoperative complications; pulmonary embolism; Thrombolytic therapy

Indexed keywords

FENTANYL; HEPARIN; ISOFLURANE; MILRINONE; NORADRENALIN; THIOPENTAL; UROKINASE;

ADULT; CASE REPORT; CONFERENCE PAPER; FIBRINOLYTIC THERAPY; HEART RIGHT VENTRICLE FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; LUNG SCINTISCANNING; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CARDIAC OUTPUT; CARDIAC OUTPUT, LOW; DIABETES MELLITUS, TYPE 1; ECHOCARDIOGRAPHY; FIBRINOLYTIC AGENTS; HERNIA, UMBILICAL; HUMANS; MALE; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; STROKE VOLUME; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0030454873     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(96)00145-6     Document Type: Conference Paper

References (41)

1. Gulba DC, Schmid C, Borst HG, Lichtlen P, Dietz R, Luft FC: Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994;343(8897):576-7.
2. Come PC, Kim D, Parker JA, Goldhaber SZ, Braunwald E, Markis JE: Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol 1987;10:971-8.
3. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990;263:2753-9.
4. Goldhaber SZ: Evolving concepts in thrombolytic therapy for pulmonary embolism. Chest 1992;101(4 Suppl):183S-185S.
5. Thrombolytic therapy in treatment: summary of an NIH consensus conference: BMJ 1980;1585-7.
6. The urokinase pulmonary embolism trial. A national cooperative study. Circulation 1973;47(suppl 2):1-108.
7. Sion A, Lopez-Majano V: Incidence of pulmonary embolism. Respiration 1978;35:181-5.
8. Dehring DJ, Arens JF: Pulmonary thromboembolism: disease recognition and patient management. Anesthesiology 1990;73:146-64.
9. Hauch O, Jorgensen LN, Khattar SC, et al: Fatal pulmonary embolism associated with surgery. An autopsy study. Acta Chir Scand 1990;156:747-9.
10. Dalen JE, Alpert JS: Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:257-70.
11. Sharma GV, Burleson VA, Sasahara AA: Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. N Engl J Med 1980;303:842-5.
12. Tibbutt DA, Davies JA, Anderson JA, et al: Comparison by controlled clinical trial of streptokinase and heparin in the treatment of life-threatening pulmonary embolism. BMJ 1974;1:343-7.
13. Goldhaber SZ: Contemporary pulmonary embolism thrombolysis. Chest 1995;107(1 Suppl):45S-51S.
14. Efstratiadis T, Munsch C, Crossman D, Taylor K: Aprotinin used in emergency coronary operation after streptokinase treatment. Ann Thorac Surg 1991;52:1320-1.
15. Severi P, Lo Pinto G, Poggio R, Andrioli G: Urokinase thrombolytic therapy of pulmonary embolism in neurosurgically treated patients. Surg Neurol 1994;42:469-70.
16. Harke H: Fibrinolytic therapy in surgically treated intensive care patients. Klin Wochenschr 1991 ;69 (Suppl 26):150-6.
17. Goldhaber SZ, Kessler CM, Heit J, et al: Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988;2(8606):293-8.
18. Goldhaber SZ, Kessler CM, Heit JA, et al: Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized, controlled multicenter trial. J Am Coll Cardiol 1992;20:24-30.
19. Verstraete M, Miller GA, Bounameaux H, et al: Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353-60.
20. Armstrong WF, Feigenbaum H, Dillon JC: Echocardiographic detection of right atrial thromboembolism. Chest 1985;87:801-6.
21. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al: A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;51:933-8.
22. Klatte EC, Becker GJ, Holden RE, Yune HY: Fibrinolytic therapy. Radiology 1986;15:619-24.
23. Lilienfeld DE, Chan E, Ehland J, Godbold JH, Landrigan PJ, Marsh G: Mortality from pulmonary embolism in the United States: 1962 to 1984. Chest 1990;98:1067-72.
24. Sasahara AA, St Martin CC: Evaluation of pulmonary embolism. Primary Cardiol 1989;15:22-34.
25. Stein PD, Athanasoulis C, Alavi A, et al: Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992;85:462-8.
26. Moses DC, Silver TM, Bookstein JJ: The complementary roles of chest radiography, lung scanning, and selective pulmonary angiography in the diagnosis of pulmonary embolism. Circulation 1974;49:179-88.
27. Mills SR, Jackson DC, Older RA, Heaston DK, Moore AV: The incidence, etiologies and avoidance of complications of pulmonary angiography in a large series. Radiology 1980;136:295-9.
28. Bookstein JJ, Fellmeth B, Roberts A, Valji K, Davis G, Machado T: Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR 1989;152:1097-100.
29. McNamara TO, Fischer JR: Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR 1985;144:769-75.
30. Handler JA, Feied CF: Acute pulmonary embolism. Aggressive therapy with anticoagulants and thrombolytics. Postgrad Med 1995;97:61-72.
31. Goldhaber SZ: Thrombolysis for pulmonary embolism. Prog Cardiovasc Dis 1991;34:113-34.
32. Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference. Ann Intern Med 1980; 93:141-4.
33. The UKEP Study: multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism. The UKEP Study Research Group. Eur Heart J 1987;8:2-10.
34. Miller GA, Sutton GC, Kerr IH, Gibson RV, Honey M: Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. BMJ 1971;2:681-4.
35. Dickie KJ, Groot WJ de, Cooley RN, Bond TP, Guest MM: Hemodynamic effects of bolus infusion of urokinase in pulmonary thromboembolism. Am Rev Respir Dis 1974;109:48-56.
36. Sasahara AA, St Martin CC: Update on the treatment of pulmonary embolism. Primary Cardiol 1989;15:41-6.
37. Bell WR: Update on urokinase and streptokinase: a comparison of their efficacy and safety. Hospital Formulary 1988;23:3.
38. Graor RA, Young JR, Risius B, Ruschhaupt WF: Comparison of cost-effectiveness of streptokinase and urokinase in the treatment of deep vein thrombosis. Ann Vasc Surg 1987;1:524-8.
39. van Breda A, Katzen BT, Deutsch AS: Urokinase versus streptokinase in local thrombolysis. Radiology 1987;165:109-11.
40. Bell WR: Thrombolytic therapy for peripheral vascular disease. In: Comerota AJ (ed): Current Thrombolytic Agents: Comparative Analysis. Philadelphia: J.B. Lippincott Co. 1995:143-74.
41. Mewissen MW, Minor PL, Beyer GA, Lipchik EO: Symptomatic native arterial occlusions: early experience with "over-the-wire" thrombolysis. JVIR 1990;1:43-7.